Another example occurred between 2001 and 2003, when a biological to treat anemia called Eprex (chemical name, erythropoietin), a supposedly identical version of a sibling called Epogen (which was manufactured in a different facility), caused a 30-fold increase in a severe kind of anemia.

FORBES: Commentary